Isabelle, a researcher, advocate and a member of the Consumer and Researcher Engagement (CaRE) program, is helping to shape the future of dementia research.

The Australian Defence Force (ADF) has commissioned Monash University to study the damaging impacts of low-level blast exposure on the brains of defence personnel, as recommended by the Royal Commission into Defence and Veteran Suicide.

Nine researchers from the Monash Biomedicine Discovery Institute (BDI) have secured more than $18 million in funding through the National Health and Medical Research Council's (NHMRC) 2026 Investigator Grant scheme.

Researchers at Monash University’s Biomedicine Discovery Institute (BDI) have developed an artificial intelligence (AI) model that could dramatically expand access to advanced spatial multi-omics research, enabling scientists to generate rich

Fifteen Monash Biomedicine Discovery Institute (BDI) researchers and educators have been recognised through Monash University's 2026 academic promotions process, reflecting the breadth of excellence across the institute's research, teaching and

A breakthrough study led by Monash University researchers has shed light on the factors shaping the intricate wiring of our brains. The research, published in the world-leading journal Cell, reveals that the brain’s complex wiring diagram,

Ten PhD candidates from across the Monash Biomedicine Discovery Institute (BDI) delivered an outstanding showcase of research excellence at the 2026 Three Minute Thesis (3MT™)  Competition, held on 27 May.

Monash University researchers have just launched Australia’s first clinical trial to test whether the psychedelic drug psilocybin is an effective treatment for persisting post-concussion symptoms.

Researchers at Monash University and The Alfred are pioneering a method of analysing blood samples to diagnose concussion in people aged over 60, the world’s most at-risk group for the condition.